Molecular Stethoscope
John Sninsky is currently serving as the Chief Scientific Officer and Chief Innovation Officer at SuperFluid Dx since October 2023. In this role, John is contributing to the company's efforts in precision medicine, specifically focusing on the early detection of Alzheimer's Disease through a liquid biopsy RNA-Seq machine learning platform. Prior to this position, John held the same titles at Molecular Stethoscope.
This person is not in any teams
This person is not in any offices
Molecular Stethoscope
Molecular Stethoscope is an early stage, molecular diagnostics company engaged in transcriptomic research and development in San Diego, California.